Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer

In May 2024, NICE published a partial review of previous guidance on tumour profiling tests for guiding adjuvant chemotherapy decisions in early breast cancer. The pre-existing guidance made recommendations for lymph node-negative (including micrometastatic disease) early breast cancer. The current update specifically considers tumour profiling tests for lymph node-positive early breast cancer but also contains the relevant information for lymph node-negative early breast cancer.

Classifications: Adjuvant & Neoadjuvant Treatment

Keywords: Neoadjuvant Chemotherapy/ NACT Tumour Profiling